BSE filing, NSE: SUNLOC. Summary written from the filing by ALFA Finder's alert engine.
Sunil Healthcare Ltd: key numbers
- Share price
- ₹67.00
- Market cap
- ₹68.71 Cr
- Revenue (annual)
- ₹87.72 Cr
- Net profit (annual)
- ₹4.01 Cr
- P/E (TTM)
- 19.3×Sector 46.5×
- Promoter holding
- 73.53%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sunil Healthcare Ltd
All →Sunil Healthcare Credit Rating
Sunil Healthcare Ltd has received a credit rating upgrade from Brickwork Ratings. Long-term bank facilities were upgraded to BWR BBB- and short-term facilities to BWR A3.
Sunil Healthcare Annual General Meeting
Sunil Healthcare Limited conducted its 52nd Annual General Meeting on September 28, 2026, via video conferencing. The proceedings included discussions on the FY 2025-26 performance and ordinary business resolutions.
Sunil Healthcare Annual General Meeting
Sunil Healthcare Ltd announced its 52nd AGM on September 28, 2026, with remote e-voting available from September 25 to September 27, 2026.
Sunil Healthcare Annual Report
Sunil Healthcare Ltd has submitted its Annual Report for the financial year 2025-26. The report includes the notice for the 52nd Annual General Meeting.
Sunil Healthcare Annual General Meeting
Sunil Healthcare Limited has issued a notice for its 52nd Annual General Meeting scheduled for September 28, 2026. The meeting will address financial statement adoption and re-appointment.
Sunil Healthcare Q1 FY27 Results: Net Profit ₹0.5 Cr, Down 44.4% YoY
Sunil Healthcare Ltd reported revenue from operations of ₹19 Cr (-15.9% YoY) and net profit of ₹0.5 Cr (-44.4% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.5 Cr · -44.4% YoY
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.